Vogel CL - Search Results

1

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.

Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, Slamon DJ, Murphy M, Novotny WF, Burchmore M, Shak S, Stewart SJ, Press M. Vogel CL, et al. J Clin Oncol. 2002 Feb 1;20(3):719-26. doi: 10.1200/JCO.2002.20.3.719. J Clin Oncol. 2002. PMID: 11821453 Clinical Trial.

2

Treatment of metastatic breast cancer.

Vogel CL. Vogel CL. Semin Oncol Nurs. 1991 Aug;7(3):194-9. doi: 10.1016/0749-2081(91)90032-k. Semin Oncol Nurs. 1991. PMID: 1718024 Review.

3

Clinical trial of high-dose oral medroxyprogesterone acetate in the treatment of metastatic breast cancer and review of the literature.

Davila E, Vogel CL, East D, Cairns V, Hilsenbeck S. Davila E, et al. Among authors: vogel cl. Cancer. 1988 Jun 1;61(11):2161-7. doi: 10.1002/1097-0142(19880601)61:11<2161::aid-cncr2820611105>3.0.co;2-2. Cancer. 1988. PMID: 2966667

4

Phase II trial of recombinant beta (IFN-betaser) interferon in the treatment of metastatic breast cancer.

Barreras L, Vogel CL, Koch G, Marcus SG. Barreras L, et al. Among authors: vogel cl. Invest New Drugs. 1988 Sep;6(3):211-5. doi: 10.1007/BF00175400. Invest New Drugs. 1988. PMID: 3192387

5

Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer.

Vogel CL, Schoenfelder J, Shemano I, Hayes DF, Gams RA. Vogel CL, et al. J Clin Oncol. 1995 May;13(5):1123-8. doi: 10.1200/JCO.1995.13.5.1123. J Clin Oncol. 1995. PMID: 7537797 Clinical Trial.

6

Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer.

Hayes DF, Van Zyl JA, Hacking A, Goedhals L, Bezwoda WR, Mailliard JA, Jones SE, Vogel CL, Berris RF, Shemano I, et al. Hayes DF, et al. Among authors: vogel cl. J Clin Oncol. 1995 Oct;13(10):2556-66. doi: 10.1200/JCO.1995.13.10.2556. J Clin Oncol. 1995. PMID: 7595707 Clinical Trial.

7

Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer.

Jones S, Winer E, Vogel C, Laufman L, Hutchins L, O'Rourke M, Lembersky B, Budman D, Bigley J, Hohneker J. Jones S, et al. J Clin Oncol. 1995 Oct;13(10):2567-74. doi: 10.1200/JCO.1995.13.10.2567. J Clin Oncol. 1995. PMID: 7595708 Clinical Trial.

8

Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer.

Weber BL, Vogel C, Jones S, Harvey H, Hutchins L, Bigley J, Hohneker J. Weber BL, et al. J Clin Oncol. 1995 Nov;13(11):2722-30. doi: 10.1200/JCO.1995.13.11.2722. J Clin Oncol. 1995. PMID: 7595730 Clinical Trial.

9

Combination chemotherapy with vinorelbine (Navelbine) and mitoxantrone for metastatic breast cancer: a review.

Vogel CL. Vogel CL. Semin Oncol. 1995 Apr;22(2 Suppl 5):61-5. Semin Oncol. 1995. PMID: 7740335 Review.

10

A phase I clinical trial of a combination of mitoxantrone, 5-fluorouracil, and high-dose leucovorin given on a day 1 and day 8 schedule to patients with metastatic breast cancer.

Vogel CL, Gomez EG. Vogel CL, et al. Am J Clin Oncol. 1994 Feb;17(1):45-9. doi: 10.1097/00000421-199402000-00010. Am J Clin Oncol. 1994. PMID: 8311006 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters